166 related articles for article (PubMed ID: 31180724)
1. Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine.
Mancia G; Tsioufis K
Future Cardiol; 2019 Jul; 15(4):259-266. PubMed ID: 31180724
[TBL] [Abstract][Full Text] [Related]
2. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension and metabolic disorders (review)].
Tabidze GA; Gezeli TD; Tsibadze TA; Dolidze NM
Georgian Med News; 2015 Feb; (239):51-6. PubMed ID: 25802450
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
[No Abstract] [Full Text] [Related]
5. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
Cicero AF; Gerocarni B; Rosticci M; Borghi C
Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
[TBL] [Abstract][Full Text] [Related]
6. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
[TBL] [Abstract][Full Text] [Related]
7. Fixed-dose combination lercanidipine/enalapril.
Hair PI; Scott LJ; Perry CM
Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
[TBL] [Abstract][Full Text] [Related]
8. Lercanidipine in patients with chronic renal failure: the ZAFRA study.
Robles NR; Ocon J; Gomez CF; Manjon M; Pastor L; Herrera J; Villatoro J; Calls J; Torrijos J; RodrÃguez VI; Rodriguez MM; Mendez ML; Morey A; Martinez FI; Marco J; Liebana A; Rincon B; Tornero F
Ren Fail; 2005; 27(1):73-80. PubMed ID: 15717638
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers: differences between subclasses.
Frishman WH
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():17-23. PubMed ID: 19845073
[TBL] [Abstract][Full Text] [Related]
12. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
Egan CG; Pontremoli R
J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
[TBL] [Abstract][Full Text] [Related]
13. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
14. [Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects].
Borghi C
Rev Med Suisse; 2006 May; 2(65):1266-7. PubMed ID: 16767882
[No Abstract] [Full Text] [Related]
15. Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
Derosa G; Mugellini A; Querci F; Franzetti I; Pesce RM; D'Angelo A; Maffioli P
Sci Rep; 2015 Aug; 5():12603. PubMed ID: 26243165
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers: their pharmacologic and therapeutic role in hypertension.
Weir MR
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():5-15. PubMed ID: 19847947
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effects of combination therapy in hypertension.
Messerli FH; Chander K
J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S17-22. PubMed ID: 10854047
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
